WFSBP^* and IAWMH^** Guidelines for the treatment of alcohol use disorders in pregnant women

References

• Adinoff B, Iranmanesh A, Veldhuis J, Fisher L. 1998. Disturbances of the stress response: the role of the HPA axis during alcohol withdrawal and abstinence. Alcohol Health Res World. 22:67–72.
   PubMedGoogle Scholar
• Ait-Daoud N, Malcolm RJ, Jr, Johnson BA. 2006. An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants. Addict Behav. 31:1628–1649.
   PubMed Web of Science ®Google Scholar
• Alvik A, Heyerdahl S, Haldorsen T, Lindemann R. 2006. Alcohol use before and during pregnancy: a population-based study. Acta Obstet Gynecol Scand. 85:1292–1298.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): American Psychiatric Association.
   Google Scholar
• Anderson BL, Dang EP, Floyd RL, Sokol R, Mahoney J, Schulkin J. 2010. Knowledge, opinions, and practice patterns of obstetrician-gynecologists regarding their patients’ use of alcohol. J Addict Med. 4:114–121.
   PubMed Web of Science ®Google Scholar
• Antonelli M, Ferrulli A, Sestito L, Vassallo GA, Tarli C, Mosoni C, Rando MM, Mirijello A, Gasbarrini A, Addolorato G. 2017. Alcohol addiction – the safety of available approved treatment options. Expert Opin Drug Saf. 20:1–9.
   Google Scholar
• Armstrong MA, Kaskutas LA, Witbrodt J, Taillac CJ, Hung YY, Osejo VM, Escobar GJ. 2009. Using drink size to talk about drinking during pregnancy: a randomized clinical trial of early start plus. Soc Work Health Care. 48:90–103.
   PubMed Web of Science ®Google Scholar
• Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ, WFSBP Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders, Zohar J, Hollander E, Kasper S, Möller HJ, et al. 2008. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision. World J Biol Psychiatry. 9:248–312.
   PubMed Web of Science ®Google Scholar
• Barlow A, Mullany B, Neault N, Goklish N, Billy T, Hastings R, Lorenzo S, Kee C, Lake K, Redmond C, et al. 2015. Paraprofessional-delivered home-visiting intervention for American Indian teen mothers and children: 3-year outcomes from a randomized controlled trial. Am J Psychiatry. 172:154–162.
   PubMed Web of Science ®Google Scholar
• Barrons R, Roberts N. 2010. The role of carbamazepine and oxcarbazepine in alcohol withdrawal syndrome. J Clin Pharm Ther. 35:153–167.
   PubMed Web of Science ®Google Scholar
• Bellantuono C, Tofani S, Di Sciascio G, Santone G. 2013. Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview. Gen Hosp Psychiatry. 35:3–8.
   PubMed Web of Science ®Google Scholar
• Bentley SM, Melville JL, Berry BD, Katon WJ. 2007. Implementing a clinical and research registry in obstetrics: overcoming the barriers. Gen Hosp Psychiatry. 29:192–198.
   PubMed Web of Science ®Google Scholar
• Berglund M, Thelander S, Salaspuro M, Franck J, Andreasson S, Ojehagen A. 2003. Treatment of alcohol abuse: an evidence-based review. Alcohol Clin Exp Res. 27:1645–1656.
   PubMed Web of Science ®Google Scholar
• Bernard N, Beghin D, Hüttel E, Dunstan H, Ieri A, Te Winkel B. 2014. Pregnancy outcome after in utero exposure to baclofen: an ENTIS collaborative study. Birth Defects Res. 100:525.
   Google Scholar
• Berner MM, Habbig S, Harter M. 2004. Quality of guidelines for the treatment of alcohol related disorders: a systematic review and content analysis. Fortschr Neurol Psychiatr. 72:696–704.
   PubMed Web of Science ®Google Scholar
• Bernstein JA, Bernstein E, Heeren TC. 2010. Mechanisms of change in control group drinking in clinical trials of brief alcohol intervention: implications for bias toward the null. Drug Alcohol Rev. 29:498–507.
   PubMed Web of Science ®Google Scholar
• Bertholet N, Daeppen JB, Wietlisbach V, Fleming M, Burnand B. 2005. Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis. Arch Intern Med. 165:986–995.
   PubMed Web of Science ®Google Scholar
• Bhat A, Hadley A. 2015. The management of alcohol withdrawal in pregnancy: case report, literature review and preliminary recommendations. Gen Hosp Psychiatry. 37:273.e1–e273.
   Web of Science ®Google Scholar
• Bishop D, Borkowski L, Couillard M, Allina A, Baruch S, Wood S. 2017. “Bridging the Divide White Paper: Pregnant Women and Substance Use: Overview of Research & Policy in the United States.” Jacobs Institute of Women’s Health. Paper 5.
   Google Scholar
• Bologa-Campeanu M, Koren G, Rieder M, McGuigan M. 1988. Prenatal adverse effects of various drugs and chemicals. A review of substances of frequent concern to mothers in the community. Med Toxicol Adverse Drug Exp. 3:307–323.
   PubMedGoogle Scholar
• Bonnot O, Vollset SE, Godet PF, d’Amato T, Dalery J, Robert E. 2003. In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam? Encephale 29:553–559.
   PubMed Web of Science ®Google Scholar
• Bottoms S, Martier S, Sokol R. 1989. Refinements in screening for risk drinking in reproductive-aged women: the ‘NET’ results. Alcohol Clin Exp Res. 13:339.
   Google Scholar
• Brandlistuen RE, Ystrom E, Hernandez-Diaz S, Skurtveit S, Selmer R, Handal M, Nordeng H. 2017. Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study. PLoS One. 12:e0181042.
   PubMed Web of Science ®Google Scholar
• Brennan R, Van Hout MC. 2014. Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups. J Psychoactive Drugs. 46:243–251.
   PubMed Web of Science ®Google Scholar
• Brunt TM, van Amsterdam JG, van den Brink W. 2014. GHB, GBL and 1,4-BD addiction. Curr Pharm Des. 20:4076–4085.
   PubMed Web of Science ®Google Scholar
• Burd L. 2016. Fetal alcohol spectrum disorder: complexity from comorbidity. Lancet. 387:926–927.
   PubMed Web of Science ®Google Scholar
• Burns E, Gray R, Smith LA. 2010. Brief screening questionnaires to identify problem drinking during pregnancy: a systematic review. Addiction. 105:601–614.
   PubMed Web of Science ®Google Scholar
• Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. 1998. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory care quality improvement project (ACQUIP). Alcohol Use Disorders identification Test. Arch Intern Med. 158:1789–1795.
   PubMed Web of Science ®Google Scholar
• Caetano R, Ramisetty-Mikler S, Floyd LR, McGrath C. 2006. The epidemiology of drinking among women of child-bearing age. Alcohol Clin Exp Res. 30:1023–1030.
   PubMed Web of Science ®Google Scholar
• Calderon-Margalit R, Qiu C, Ornoy A, Siscovick DS, Williams MA. 2009. Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy. Am J Obstet Gynecol. 201:579.e1–579.e8.
   Web of Science ®Google Scholar
• Caputo F, Vignoli T, Tarli C, Domenicali M, Zoli G, Bernardi M, Addolorato G. 2016. A brief up-date of the use of sodium oxybate for the treatment of alcohol use disorder. Int J Environ Res PublicHealth. 513:290.
   Google Scholar
• Carson G, Cox LV, Crane J, Croteau P, Graves L, Kluka S, Koren G, Martel MJ, Midmer D, Nulman I, et al. 2010. Alcohol use and pregnancy consensus clinical guidelines. J Obstet Gynaecol Can. 32:S1–S31.
   PubMedGoogle Scholar
• Ceperich SD, Ingersoll KS. 2011. Motivational interviewing + feedback intervention to reduce alcohol-exposed pregnancy risk among college binge drinkers: determinants and patterns of response. J Behav Med. 34:381–395.
   PubMed Web of Science ®Google Scholar
• Chan GM, Hoffman RS, Gold JA, Whiteman PJ, Goldfrank LR, Nelson LS. 2009. Racial variations in the incidence of severe alcohol withdrawal. J Med Toxicol. 5:8–14.
   PubMedGoogle Scholar
• Chan AW, Pristach EA, Welte JW, Russell M. 1993. Use of the TWEAK test in screening for alcoholism/heavy drinking in three populations. Alcohol Clin Exp Res. 17:1188–1192.
   PubMed Web of Science ®Google Scholar
• Chang G, McNamara TK, Orav EJ, Koby D, Lavigne A, Ludman B, Vincitorio NA, Wilkins-Haug L. 2005. Brief intervention for prenatal alcohol use: a randomized trial. Obstet Gynecol. 105:991–998.
   PubMed Web of Science ®Google Scholar
• Chang G, Wilkins-Haug L, Berman S, Goetz MA. 1999. Brief intervention for alcohol use in pregnancy: a randomized trial. Addiction. 94:1499–1508.
   PubMed Web of Science ®Google Scholar
• Chang G, Wilkins-Haug L, Berman S, Goetz MA, Behr H, Hiley A. 1998. Alcohol use and pregnancy: improving identification. Obstet Gynecol. 91:892–898.
   PubMed Web of Science ®Google Scholar
• Chasnoff IJ, Landress HJ, Barrett ME. 1990. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med. 322:1202–1206.
   PubMed Web of Science ®Google Scholar
• Chasnoff I. 2003. Neonatal abstinence syndrome. Neo Rev. 10(5):e222–e229. doi:10.1542/neo.10?5-e222.
   Google Scholar
• Chick J. 1999. Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Saf. 20:427–435.
   PubMed Web of Science ®Google Scholar
• Choi IY, Allan AM, Cunningham LA. 2005. Moderate fetal alcohol exposure impairs the neurogenic response to an enriched environment in adult mice. Alcohol Clin Exp Res. 29:2053–2062.
   PubMed Web of Science ®Google Scholar
• Chudley AE, Kilgour AR, Cranston M, Edwards M. 2007. Challenges of diagnosis in fetal alcohol syndrome and fetal alcohol spectrum disorder in the adult. Am J Med Genet. 145C:261–272.
   PubMed Web of Science ®Google Scholar
• Cohen E, Keshet G, Shavit Y, Weinstock M. 1996. Prenatal naltrexone facilitates male sexual behavior in the rat. Pharmacol Biochem Behav. 54:183–188.
   PubMed Web of Science ®Google Scholar
• Cook JL, Green CR, Lilley CM, Anderson SM, Baldwin ME, Chudley AE, Conry JL, LeBlanc N, Loock CA, Lutke J, et al. 2016. Fetal alcohol spectrum disorder: a guideline for diagnosis across the lifespan. CMAJ. 188:191–197.
   PubMed Web of Science ®Google Scholar
• Cornelius MD, De Genna NM, Goldschmidt L, Larkby C, Day NL. 2016. Prenatal alcohol and other early childhood adverse exposures: Direct and indirect pathways to adolescent drinking. Neurotoxicol Teratol. 55:8–15.
   PubMed Web of Science ®Google Scholar
• Cowen MS, Chen F, Lawrence AJ. 2004. Neuropeptides: implications for alcoholism. J Neurochem. 89:273–285.
   PubMed Web of Science ®Google Scholar
• Crawford-Williams F, Fielder A, Mikocka-Walus A, Esterman A. 2015. A critical review of public health interventions aimed at reducing alcohol consumption and/or increasing knowledge among pregnant women. Drug Alcohol Rev. 34:154–161.
   PubMed Web of Science ®Google Scholar
• Cunningham JA, Breslin FC. 2004. Only one in three people with alcohol abuse or dependence ever seek treatment. Addict Behav. 29:221–223.
   PubMed Web of Science ®Google Scholar
• Cunnington MC, Weil JG, Messenheimer JA, Ferber S, Yerby M, Tennis P. 2011. Final results from 18 years of the International Lamotrigine Pregnancy Registry. Neurology. 76:1817–1823.
   PubMed Web of Science ®Google Scholar
• Dehaene P, Titran M, Dubois D. 1984. Pierre Robin syndrome and heart malformations in a newborn infant. The role of disulfiram during pregnancy? Presse Med. 2613:1394–1395.
   Google Scholar
• De Jong J, Garne E, de Jong-van den Berg LTW, Wang H. 2016. The risk of specific congenital anomalies in relation to newer antiepileptic drugs: a literature review. Drugs Real World Outcomes. 3:131–143.
   PubMedGoogle Scholar
• Del Campo M, Jones KL. 2017. A review of the physical features of the fetal alcohol spectrum disorders. Eur J Med Genet. 60:55–64.
   PubMed Web of Science ®Google Scholar
• Delrahim-Howlett K, Chambers D, Clapp JD, Xu RH, Duke K, Moyer RJ, Van Sickle D. 2011. Web-based assessment and brief intervention for alcohol use in women of childbearing potential: a report of the primary findings. Alcohol Clin Exp Res. 35:1331–1338.
   PubMed Web of Science ®Google Scholar
• DeVido J, Bogunovic O, Weiss RD. 2015. Alcohol use disorders in pregnancy. Harv Rev Psychiatry. 23:112–121.
   PubMed Web of Science ®Google Scholar
• DeVille KA, Kopelman LM. 1998. Moral and social issues regarding pregnant women who use and abuse drugs. Obstet Gynecol Clin North Am. 25:237–254.
   PubMed Web of Science ®Google Scholar
• DeVito EE, Worhunsky PD, Carroll KM, Rounsaville BJ, Kober H, Potenza MN. 2012. A preliminary study of the neural effects of behavioral therapy for substance use disorders. Drug Alcohol Depend. 122:228–235.
   PubMed Web of Science ®Google Scholar
• Doi L, Cheyne H, Jepson R. 2014. Alcohol brief interventions in Scottish antenatal care: a qualitative study of midwives’ attitudes and practices. BMC Pregnancy Childbirth. 14:170.
   PubMed Web of Science ®Google Scholar
• Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR. 1998. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ. 317:839–843.
   PubMed Web of Science ®Google Scholar
• Donoghue K, Elzerbi C, Saunders R, Whittington C, Pilling S, Drummond C. 2015. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis. Addiction. 110:920–930.
   PubMed Web of Science ®Google Scholar
• Duncan SD, Devlin LA. 2013. Use of baclofen for withdrawal in a preterm infant. J Perinatol. 33:327–328.
   PubMed Web of Science ®Google Scholar
• Dutta N, Helton SG, Schwandt M, Zhu X, Momenan R, Lohoff FW. 2016. Genetic variation in the Vesicular Monoamine Transporter 1 (VMAT1/SLC18A1) gene and alcohol withdrawal severity. Alcohol Clin Exp Res. 40:474–481.
   PubMed Web of Science ®Google Scholar
• Enato E, Moretti M, Koren G. 2011. The fetal safety of benzodiazepines: an updated meta-analysis. J Obstet Gynaecol Can. 33:46–48.
   PubMedGoogle Scholar
• Ethen MK, Ramadhani TA, Scheuerle AE, Canfield MA, Wyszynski DF, Druschel CM, Romitti PA, National Birth Defects Prevention Study. 2009. Alcohol consumption by women before and during pregnancy. Matern Child Health J. 13:274–285.
   PubMed Web of Science ®Google Scholar
• Eyer F, Schreckenberg M, Hecht D, Adorjan K, Schuster T, Felgenhauer N, Pfab R, Strubel T, Zilker T. 2011. Carbamazepine and valproate as adjuncts in the treatment of alcohol withdrawal syndrome: a retrospective cohort study. Alcohol. 46:177–184.
   Web of Science ®Google Scholar
• Farid WO, Lawrence AJ, Krstew EV, Tait RJ, Hulse GK, Dunlop SA. 2012. Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood. PLoS One. 7:e52812.
   PubMed Web of Science ®Google Scholar
• Fleming MF, Balousek SL, Grossberg PM, Mundt MP, Brown D, Wiegel JR, Zakletskaia LI, Saewyc EM. 2010. Brief physician advice for heavy drinking college students: a randomized controlled trial in college health clinics. J Stud Alcohol Drugs. 71:23–31.
   PubMed Web of Science ®Google Scholar
• Floyd RL, Sobell M, Velasquez MM, Ingersoll K, Nettleman M, Sobell L, Mullen PD, Ceperich S, von Sternberg K, Bolton B, et al. 2007. Preventing alcohol-exposed pregnancies: a randomized controlled trial. Am J Prev Med. 32:1–10.
   PubMed Web of Science ®Google Scholar
• Förg A, Hein J, Volkmar K, Winter M, Richter C, Heinz A, Müller CA. 2012. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial. Alcohol. 47:149–155.
   Web of Science ®Google Scholar
• Freeman EH, Delaney RM. 2016. Neonatal Baclofen withdrawal: a case report of an infant presenting with severe feeding difficulties. J Pediatr Nurs. 31:346–349.
   PubMed Web of Science ®Google Scholar
• Freynhagen R, Backonja M, Schug S, Lyndon G, Parsons B, Watt S, Behar R. 2016. Pregabalin for the treatment of drug and alcohol withdrawal symptoms: a comprehensive review. CNS Drugs. 30:1191–1200.
   PubMed Web of Science ®Google Scholar
• Fujii H, Goel A, Bernard N, Pistelli A, Yates LM, Stephens S, Han JY, Matsui D, Etwell F, Einarson TR, et al. 2013. Pregnancy outcomes following gabapentin use: results of a prospective comparative cohort study. Neurology 80:1565–1570.
   PubMed Web of Science ®Google Scholar
• Gahr M, Franke B, Freudenmann RW, Kölle MA, Schönfeldt-Lecuona C. 2013. Concerns about pregabalin: further experience with ist potential of causing addictive behavior. J Addict Med. 7:147–149.
   PubMed Web of Science ®Google Scholar
• Gardner RJ, Clarkson JE. 1981. A malformed child whose previously alcoholic mother had taken disulfiram. N Z Med J. 2593:184–186.
   Google Scholar
• Gebara CF, Bhona FM, Ronzani TM, Lourenço LM, Noto AR. 2013. Brief intervention and decrease of alcohol consumption among women: a systematic review. Subst Abuse Treat Prev Policy. 8:31.
   PubMed Web of Science ®Google Scholar
• Gentile S. 2014. Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions. CNS Spectr. 19:305–315.
   PubMed Web of Science ®Google Scholar
• Gianoulakis C. 1989. The effect of ethanol on the biosynthesis and regulation of opioid peptides. Experientia. 45:428–435.
   PubMedGoogle Scholar
• Gianoulakis C, de Waele JP, Thavundayil J. 1996. Implication of the endogenous opioid system in excessive ethanol consumption. Alcohol. 13:19–23.
   PubMed Web of Science ®Google Scholar
• Gidai J, Acs N, Banhidy F, Czeizel AE. 2008. A study of the effects of large doses of medazepam used for self-poisoning in 10 pregnant women on fetal development. Toxicol Ind Health. 24:61–68.
   PubMed Web of Science ®Google Scholar
• Gillberg C. 1977. Floppy infant syndrome and maternal diazepam. Lancet. 2:244.
   PubMedGoogle Scholar
• Goldkamp J, Blaskiewicz R, Myles T. 2011. Stiff person syndrome and pregnancy. Obstet Gynecol. 118:454–457.
   PubMed Web of Science ®Google Scholar
• Guelinckx I, Devlieger R, Vansant G. 2011. Alcohol during pregnancy and lactation: recommendations versus real intake. Arch Public Health. 68:134–142.
   Google Scholar
• Handmaker NS, Miller WR, Manicke M. 1999. Findings of a pilot study of motivational interviewing with pregnant drinkers. J Stud Alcohol. 60:285–287.
   PubMed Web of Science ®Google Scholar
• Hans SL. 1999. Demographic and psychosocial characteristics of substance-abusing pregnant women. Clin Perinatol. 26:55–74.
   PubMed Web of Science ®Google Scholar
• Harris SK, Knight JR. 2014. Putting the screen in screening: technology-based alcohol screening and brief interventions in medical settings. Alcohol Res. 36:63–79.
   PubMed Web of Science ®Google Scholar
• Harrison P, Sidebottom A. 2009. Alcohol and drug use before and during pregnancy: an examination of use patterns and predictors of cessation. Matern Child Health J. 13:386–394.
   PubMed Web of Science ®Google Scholar
• Heberlein A, Leggio L, Stichtenoth D, Hillemacher T. 2012. The treatment of alcohol and opioid dependence in pregnant women. Curr Opin Psychiatry. 25:559–564.
   PubMed Web of Science ®Google Scholar
• Heinz A, Rommelspacher H, Graf KJ, Kurten I, Otto M, Baumgartner A. 1995. Hypothalamic-pituitary-gonadal axis, prolactin, and cortisol in alcoholics during withdrawal and after three weeks of abstinence: Comparison with healthy control subjects. Psychiatry Res. 56:81–95.
   PubMed Web of Science ®Google Scholar
• Helmbrecht GD, Hoskins IA. 1993. First trimester disulfiram exposure: report of two cases. Am J Perinatol. 10:5–7.
   PubMed Web of Science ®Google Scholar
• Henderson J, Gray R, Brocklehurst P. 2007. Systematic review of effects of low-moderate prenatal alcohol exposure on pregnancy outcome. BJOG. 114:243–252.
   PubMed Web of Science ®Google Scholar
• Hettema J, Steele J, Miller WR. 2005. Motivational interviewing. Annu Rev Clin Psychol. 1:91–111.
   PubMed Web of Science ®Google Scholar
• Himes SK, Dukes KA, Tripp T, Petersen JM, Raffo C, Burd L, Odendaal H, Elliott AJ, Hereld D, Signore C, et al. 2015. Clinical sensitivity and specificity of meconium fatty acid ethyl ester, ethyl glucuronide, and ethyl sulfate for detecting maternal drinking during pregnancy. Clin Chem. 61:523–532.
   PubMed Web of Science ®Google Scholar
• Holmes LB, Baldwin EJ, Smith CR, Habecker E, Glassman L, Wong SL, Wyszynski DF. 2008. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology. 70:2152–2158.
   PubMed Web of Science ®Google Scholar
• Hulse GK, O’Neill G, Pereira C, Brewer C. 2001. Obstetric and neonatal outcomes associated with maternal naltrexone exposure. Aust N Z J Obstet Gynaecol. 41:424–428.
   PubMed Web of Science ®Google Scholar
• Ingersoll KS, Ceperich SD, Hettema JE, Farrell-Carnahan L, Penberthy JK. 2013. Preconceptional motivational interviewing interventions to reduce alcohol-exposed pregnancy risk. J Subst Abuse Treat. 44:407–416.
   PubMed Web of Science ®Google Scholar
• Iqbal MM, Sobhan T, Ryals T. 2002. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr Serv. 53:39–49.
   PubMed Web of Science ®Google Scholar
• Jentink J, Dolk H, Loane MA, Morris JK, Wellesley D, Garne E, de Jong-van den Berg L. EUROCAT Antiepileptic Study Working Group. 2010. Intratuterine exposure to carbamazepine ans specific congenital malformations, systematic review and case-control study. BMJ. 341:c6581.
   PubMed Web of Science ®Google Scholar
• Jesse S, Bräthen G, Ferrara M, Keindl M, Ben-Menachem E, Tanasescu R, Brodtkorb E, Hillbom M, Leone MA, Ludolph AC. 2017. Alcohol withdrawal syndrome: mechanisms, manifestations and management. Acta Neurol Scand. 135:4–16.
   PubMed Web of Science ®Google Scholar
• Jonas DE, Amick HR, Feltner C, Bobashev G, Thomas K, Wines R, Kim MM, Shanahan E, Gass CE, Rowe CJ, et al. 2014. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 311:1889–1900.
   PubMed Web of Science ®Google Scholar
• Jones LA. 2011. Systematic review of alcohol screening tools for use in the emergency department. Emerg Med J. 28:182–191.
   PubMed Web of Science ®Google Scholar
• Jones KL, Chambers CD, Hill LL, Hull AD, Riley EP. 2006. Alcohol use in pregnancy: inadequate recommendations for an increasing problem. BJOG. 113:967–968.
   PubMed Web of Science ®Google Scholar
• Joya X, Mazarico E, Ramis J, Pacifici R, Salat-Batlle J, Mortali C, García-Algar O, Pichini S. 2016. Segmental hair analysis to assess effectiveness of single-session motivational intervention to stop ethanol use during pregnancy. Drug Alcohol Depend. 158:45–51.
   PubMed Web of Science ®Google Scholar
• Källén B, Borg N, Reis M. 2013. The use of central nervous system active drugs during pregnancy. Pharmaceuticals (Basel). 6:1221–1286.
   PubMedGoogle Scholar
• Keating GM. 2014. Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence. Clin Drug Investig. 34:63–80.
   PubMed Web of Science ®Google Scholar
• Kellog C, Tervo D, Ison J, Parisi T, Miller RK. 1980. Prenatal exposure to diazepam alters behavioral development in rats. Science. 207:205–207.
   PubMed Web of Science ®Google Scholar
• Kelly Y, Iacovou M, Quigley MA, Gray R, Wolke D, Kelly J, Sacker A. 2013. Light drinking versus abstinence in pregnancy – behavioural and cognitive outcomes in 7-year-old children: a longitudinal cohort study. BJOG. 120:1340–1347.
   PubMed Web of Science ®Google Scholar
• Kelty E, Hulse G. 2017. A retrospective cohort study of birth outcomes in neonates exposed to naltrexone in utero: a comparison with methadone-, buprenorphine- and non-opioid-exposed neonates. Drugs. 77:1211–1219.
   PubMed Web of Science ®Google Scholar
• Keshet GI, Weinstock M. 1995. Maternal naltrexone prevents morphological and behavioral alterations induced in rats by prenatal stress. Pharmacol Biochem Behav. 50:413–419.
   PubMed Web of Science ®Google Scholar
• Kieviet N, Dolman KM, Honig A. 2013. The use of psychotropic medication during pregnancy: how about the newborn?. Neuropsychiatr Dis Treat. 9:1257–1266.
   PubMed Web of Science ®Google Scholar
• Kleber HD, Weiss RD, Anton RF, Jr, George TP, Greenfield SF, Kosten TR, O’Brien CP, Rounsaville BJ, Strain EC, Ziedonis DM, et al. 2007. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry. 164:5–123.
   PubMed Web of Science ®Google Scholar
• Krupitsky EM, Rudenko AA, Burakov AM, Slavina TY, Grinenko AA, Pittman B, Gueorguieva R, Petrakis IL, Zvartau EE, Krystal JH. 2007. Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam. Alcohol Clin Exp Res. 31:604–611.
   PubMed Web of Science ®Google Scholar
• Kypri K, Langley JD, Saunders JB, Cashell-Smith ML. 2007. Assessment may conceal therapeutic benefit: findings from a randomized controlled trial for hazardous drinking. Addiction. 102:62–70.
   PubMed Web of Science ®Google Scholar
• Laegreid L, Hagberg G, Lundberg A. 1992. Neurodevelopment in late infancy after prenatal exposure to benzodiazepines-a prospective study. Neuropediatrics. 23:60–67.
   PubMed Web of Science ®Google Scholar
• Lamy S, Hennart B, Houivet E, Dulaurent S, Delavenne H, Benichou J, Allorge D, Marret S, Thibaut F. for the Perinatal network of Upper-Normandy. 2017. Assessment of tobacco, alcohol and cannabinoid metabolites in 645 meconium samples of newborns compared to maternal self-reports. J Psychiatr Res. 90:86–93.
   PubMed Web of Science ®Google Scholar
• Lamy S, Laqueille X, Thibaut F. 2015. Consequences of tobacco, cocaine and cannabis consumption during pregnancy on the pregnancy itself, on the newborn and on child development: a review. Encéphale. 41:13–20.
   Web of Science ®Google Scholar
• Lamy S, Thibaut F. 2010. Etat des lieux de la consommation de substances psychoactives par les femmes enceintes. Encéphale. 36:33–38.
   PubMedGoogle Scholar
• Lamy S, Thibaut F. 2011. Biological markers of exposure of foetus to alcohol during pregnancy. In: Hoffman JD, editor. Pregnancy and alcohol consumption. Public Health in the 21st century. Inc New York, USA: Nova Science Publishers; Ch 15, p. 347–358.
   Google Scholar
• Lange S, Probst C, Gmel G, Rehm J, Burd L, Popova S. 2017. Global prevalence of fetal alcohol spectrum disorder among children and youth: a systematic review and meta-analysis. JAMA Pediatr. 171:948–956.
   PubMed Web of Science ®Google Scholar
• Lange S, Shield K, Koren G, Rehm J, Popova S. 2014. A comparison of the prevalence of prenatal alcohol exposure obtained via maternal self-reports versus meconium testing: a systematic literature review and meta-analysis. BMC Pregnancy Childbirth. 14:127.
   PubMed Web of Science ®Google Scholar
• Latino-Martel P, Arwidson P, Ancellin R, Druesne-Pecollo N, Hercberg S, Le Quellec-Nathan M, Le-Luong T, Maraninchi D. 2011. Alcohol consumption and cancer risk: revisiting guidelines for sensible drinking. CMAJ. 183:1861–1865.
   PubMed Web of Science ®Google Scholar
• Lechat P. 1966. Toxicological and pharmacological properties of clomethiazole. Acta Psychiatr Scand Suppl.Scand192:15–22.
   PubMedGoogle Scholar
• Lemoine P, Harousseau H, Borteyru JP, Menuet JC. 1968. Les enfants de parents alcooliques – anomalies observées: à propos de 127 cas. Ouest Med. 21:476–482.
   Google Scholar
• Leone MA, Vigan-Taglianti F, Avanzi G, Brambilla R, Faggiano F. 2010. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. Cochrane Database Syst Rev. (2):CD006266.
   PubMed Web of Science ®Google Scholar
• Lingford-Hughes AR, Welch S, Nutt DJ. 2004. Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology. J Psychopharmacol (Oxford). 18:293–335.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang LN. 2017. Baclofen for alcohol withdrawal. Cochrane Database Syst Rev. 20:CD008502.
   Google Scholar
• Lundin A, Hallgren M, Balliu N, Forsell Y. 2015. The use of alcohol use disorders identification test (AUDIT) in detecting alcohol use disorder and risk drinking in the general population: validation of AUDIT using schedules for clinical assessment in neuropsychiatry. Alcohol Clin Exp Res. 39:158–165.
   PubMed Web of Science ®Google Scholar
• Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW. 2013. Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction. 108:275–293.
   PubMed Web of Science ®Google Scholar
• Maldonado JR, Sher Y, Das S, Hills-Evans K, Frenklach A, Lolak S, Talley R, Neri E. 2015. Prospective Validation Study of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in medically ill inpatients: a new scale for the prediction of complicated alcohol withdrawal syndrome. Alcohol. 50:509–518.
   Web of Science ®Google Scholar
• Mårdby AC, Lupattelli A, Hensing G, Nordeng H. 2017. Consumption of alcohol during pregnancy-A multinational European study. Women Birth. 30:e207–e213.
   PubMed Web of Science ®Google Scholar
• May PA, Baete A, Russo J, Elliott AJ, Blankenship J, Kalberg WO, Buckley D, Brooks M, Hasken J, Abdul-Rahman O, et al. 2014. Prevalence and characteristics of fetal alcohol spectrum disorders. Pediatrics. 134:855–866.
   PubMed Web of Science ®Google Scholar
• May PA, Gossage JP, Kalberg WO, Robinson LK, Buckley D, Manning M, Hoyme HE. 2009. Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies. Dev Disabil Res Rev. 15:176–192.
   PubMed Web of Science ®Google Scholar
• May PA, Hasken JM, Blankenship J, Marais AS, Joubert B, Cloete M, de Vries MM, Barnard M, Botha I, Roux S, et al. 2016. Breastfeeding and maternal alcohol use: prevalence and effects on child outcomes and fetal alcohol spectrum disorders. Reprod Toxicol. 63:13–21.
   PubMed Web of Science ®Google Scholar
• Mayfield D, McLeod G, Hall P. 1974. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry. 131:1121–1123.
   PubMed Web of Science ®Google Scholar
• Mayo-Smith MF. 1997. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA. 278:144–151.
   PubMed Web of Science ®Google Scholar
• Mayo-Smith MF, Beecher LH, Fischer TL, Gorelick DA, Guillaume JL, Hill A, Jara G, Kasser C, Melbourne J. Working Group on the Management of Alcohol Withdrawal Delirium, Practice Guidelines Committee, American Society of Addiction Medicine. 2004. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med. 164:2068–2012. Erratum in: Arch Intern Med. 164(18):2068.
   PubMedGoogle Scholar
• McDonough M, Kennedy N, Glasper A, Bearn J. 2004. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. Drug Alcohol Depend. 75:3–9.
   PubMed Web of Science ®Google Scholar
• McElhatton PR. 1994. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol. 8:461–475.
   PubMed Web of Science ®Google Scholar
• McLaughlin PJ, Tobias SW, Lang CM, Zagon IS. 1997. Chronic exposure to the opioid antagonist naltrexone during pregnancy: maternal and offspring effects. Physiol Behav. 62:501–508.
   PubMed Web of Science ®Google Scholar
• McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. 1992. The fifth edition of the addiction severity index. J Subst Abuse Treat. 9:199–213.
   PubMed Web of Science ®Google Scholar
• Mennecier D, Thomas M, Arvers P, Corberand D, Sinayoko L, Bonnefoy S, Harnois F, Thiolet C. 2008. Factors predictive of complicated or severe alcohol withdrawal in alcohol dependent inpatients. Gastroenterol Clin Biol. 32:792–797.
   PubMedGoogle Scholar
• Miller WR, Rollnick S. 1991. Motivational interviewing: preparing people to change addictive behavior. New York: Guilford Press. 348p.
   Google Scholar
• Mo Y, Thomas MC, Laskey CS, Shcherbakova N, Bankert ML, Halloran RH. 2018. Current practice patterns in the management of alcohol withdrawal syndrome. P T. 43:158–162.
   PubMedGoogle Scholar
• Mølgaard-Nielsen D, Hviid A. 2011. Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA. 305:1996–2002.
   PubMed Web of Science ®Google Scholar
• Molina JC, Spear NE, Spear LP, Mennella JA, Lewis MJ. 2007. The International Society for Developmental Psychobiology 39th Annual Meeting Symposium: alcohol and development: beyond fetal alcohol syndrome. Dev Psychobiol. 49:227–242.
   PubMed Web of Science ®Google Scholar
• Montag AC, Brodine SK, Alcaraz JE, Clapp JD, Allison MA, Calac DJ, Hull AD, Gorman JR, Jones KL, Chambers CD. 2015a. Preventing alcohol-exposed pregnancy among an American Indian/Alaska Native population: effect of a screening, brief intervention, and referral to treatment intervention. Alcohol Clin Exp Res. 39:126–135.
   PubMed Web of Science ®Google Scholar
• Montag AC, Brodine SK, Alcaraz JE, Clapp JD, Allison MA, Calac DJ, Hull AD, Gorman JR, Jones KL, Chambers CD. 2015b. Effect of depression on risky drinking and response to a screening, brief intervention, and referral to treatment intervention. Am J Public Health. 105:1572–1576.
   PubMed Web of Science ®Google Scholar
• Moran LR, Almeida PG, Worden S, Huttner KM. 2004. Intrauterine baclofen exposure: a multidisciplinary approach. Pediatrics. 114:e267–e269.
   PubMed Web of Science ®Google Scholar
• Morrell MJ. 1996. The new antiepileptic drugs and women: efficacy, reproductive health, pregnancy, and fetal outcome. Epilepsia. 37:S34–S44.
   PubMed Web of Science ®Google Scholar
• Morrow J, Russell A, Guthrie E, Pearsons L, Robertson I, Waddell R, Irwin B, McGuivern RC, Morrison PJ, Craig J. 2006. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry. 77:193–198.
   PubMed Web of Science ®Google Scholar
• Mostacci B, Poluzzi E, D’Alessandro R, Cocchi G, Tinuper P. on behalf of the ESPEA Study Group. 2018. Adverse pregnancy outcomes in women exposed to gabapentin and pregabalin: data from a population-based study. J Neurol Neurosurg Psychiatry. 89:223–223.
   PubMed Web of Science ®Google Scholar
• Müller CA, Geisel O, Pelz P, Higl V, Krüger J, Stickel A, Beck A, Wernecke K-D, Hellweg R, Heinz A. 2015. High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial. Eur Neuropsychopharmacol. 25:1167–1177.
   PubMed Web of Science ®Google Scholar
• Mutschler J, Kiefer F. 2013. Mechanism of action of disulfiram and treatment optimization in prevention of recurrent alcoholism. Praxis. 102:139–146.
   PubMedGoogle Scholar
• Myrick H, Malcolm R, Randall PK, Boyle E, Anton RF, Becker HC, Randall CL. 2009. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 33:1582–1588.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence (NICE). 2008. Antenatal care routine care for the healthy pregnant woman. Available at: [accessed 2009 Apr 24] http://www.nice.org.uk/nicemedia/pdf/CG62FullGuidelineCorrectedJune2008.pdf.
   Google Scholar
• National Institute for Health and Clinical Excellence (NICE). 2011. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence. Manchester, UK: National Institute for Health and Clinical Excellence.
   Google Scholar
• Nilsen P, Holmqvist M, Bendtsen P, Hultgren E, Cedergren M. 2010. Is questionnaire-based alcohol counseling more effective for pregnant women than standard maternity care? Womens Health. 19:161–167.
   Web of Science ®Google Scholar
• Nora AH, Nora JJ, Blu J. 1977. Limb-reduction anomalies in infants born to disulfiram-treated alcoholic mothers. Lancet. 2:664.
   PubMed Web of Science ®Google Scholar
• Norstedt Wikner B, Stiller CO, Bergman U, Asker C, Källén B. 2007. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: Neonatal outcome and congenital malformations. Pharmacoepidem Drug Safe. 16:1203–1210.
   PubMed Web of Science ®Google Scholar
• Ntais C, Pakos E, Kyzas P, Ioannidis JP. 2005. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev CD005063.
   PubMed Web of Science ®Google Scholar
• O’Connor MJ, Whaley SE. 2007a. Brief intervention for alcohol use by pregnant women. Am J Public Health. 97:252–258.
   PubMed Web of Science ®Google Scholar
• O’Connor MJ, Whaley SE. 2007b. Health care provider advice and risk factors associated with alcohol consumption following pregnancy recognition. Am J Public Health. 97:252–258.
   PubMed Web of Science ®Google Scholar
• O’Leary CM, Bower C. 2012. Guidelines for pregnancy: what’s an acceptable risk, and how is the evidence (finally) shaping up?. Drug Alcohol Rev. 31:170–183.
   PubMed Web of Science ®Google Scholar
• Odlaug BL, Gual A, DeCourcy J, Perry R, Pike J, Heron L, Rehm J. 2016. Alcohol Dependence, Co-occurring Conditions and Attributable Burden. Alcohol. 51:201–209.
   Web of Science ®Google Scholar
• Oh S, Reingle Gonzalez JM, Salas-Wright CP, Vaughn MG, DiNitto DM. 2017. Prevalence and correlates of alcohol and tobacco use among pregnant women in the United States: evidence from the NSDUH 2005-2014. Prev Med. 97:93–99.
   PubMed Web of Science ®Google Scholar
• Ondersma SJ, Beatty JR, Svikis DS, Strickler RC, Tzilos GK, Chang G, Divine GW, Taylor AR, Sokol RJ. 2015. Computer-delivered screening and brief intervention for alcohol use in pregnancy: a pilot randomized trial. Alcohol Clin Exp Res. 39:1219–1226.
   PubMed Web of Science ®Google Scholar
• Ornoy A, Ergaz Z. 2010. Alcohol abuse in pregnant women: effects on the fetus and newborn, mode of action and maternal treatment. Int J Environ Res Public Health. 7:364–379.
   PubMed Web of Science ®Google Scholar
• Osterman RL, Carle AC, Ammerman RT, Gates D. 2014. Single-session motivational intervention to decrease alcohol use during pregnancy. J Subst Abuse Treat. 47:10–19.
   PubMed Web of Science ®Google Scholar
• Paintner A, Williams AD, Burd L. 2012. Fetal alcohol spectrum disorders- implications for child neurology, part 1: prenatal exposure and dosimetry. J Child Neurol. 27:258–263.
   PubMed Web of Science ®Google Scholar
• Palpacuer C, Duprez R, Huneau A, Locher C, Boussageon R, Laviolle B, Naudet F. 2018. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate. Addiction. 113(2):220–237.
   PubMed Web of Science ®Google Scholar
• Pani PP, Trogu E, Pacini M, Maremmani I. 2014. Anticonvulsants for alcohol dependence. Cochrane Database Syst Rev. 13:CD008544.
   Google Scholar
• Payne JM, Watkins RE, Jones HM, Reibel T, Mutch R, Wilkins AA, Whitlock J, Bower C. 2014. Midwives’ knowledge, attitudes and practice about alcohol exposure ant the risk of fetal alcohol spectrum disorder. BMC Pregnancy Childbirth. 14:377.
   PubMed Web of Science ®Google Scholar
• Penberthy JK, Hook JN, Hettema J, Farrell-Carnahan L, Ingersoll K. 2013. Depressive symptoms moderate treatment response to brief intervention for prevention of alcohol exposed pregnancy. J Subst Abuse Treat. 45:335–342.
   PubMed Web of Science ®Google Scholar
• Perry EC. 2014. Inpatient management of acute alcohol withdrawal syndrome. CNS Drugs. 28:401–410.
   PubMed Web of Science ®Google Scholar
• Platt L, Melendez-Torres GJ, O’Donnell A, Bradley J, Newbury-Birch D, Kaner E, Ashton C. 2016. How effective are brief interventions in reducing alcohol consumption: do the setting, practitioner group and content matter? Findings from a systematic review and meta-regression analysis. BMJ Open. 6:e011473.
   PubMed Web of Science ®Google Scholar
• Płotka J, Narkowicz S, Polkowska Z, Biziuk M, Namieśnik J. 2014. Effects of addictive substances during pregnancy and infancy and their analysis in biological materials. Rev Environ Contam Toxicol. 227:55–77.
   PubMed Web of Science ®Google Scholar
• Popova S, Lange S, Probst C, Gmel G, Rehm J. 2017. Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet Glob Health. 5:e290–e299.
   PubMed Web of Science ®Google Scholar
• Prescrire Int. 2015. Baclofen and pregnancy: birth defects and withdrawal symptoms. Prescrire Int. 24:214.
   PubMedGoogle Scholar
• Ratnayaka BD, Dhaliwal H, Watkin S. 2001. Drug points: Neonatal convulsions after withdrawal of baclofen. BMJ. 323:85.
   PubMed Web of Science ®Google Scholar
• Rayburn WF, Bogenschutz MP. 2004. Pharmacotherapy for pregnant women with addictions. Am J Obstet Gynecol. 191:1885–1897.
   PubMed Web of Science ®Google Scholar
• Reitnauer PJ, Callanan NP, Farber RA, Aylsworth AS. 1997. Aylsworth ASPrenatal exposure to disulfiram implicated in the cause of malformations in discordant monozygotic twins. Teratology. 56:358–362.
   PubMedGoogle Scholar
• Rementeria JL, Bhatt K. 1977. Withdrawal symptoms in neonates from intrauterine exposure to diazepam. J Pediatr. 90:123–126.
   PubMed Web of Science ®Google Scholar
• Rendall-Mkosi K, Morojele N, London L, Moodley S, Singh C, Girdler-Brown B. 2013. A randomized controlled trial of motivational interviewing to prevent risk for an alcohol-exposed pregnancy in the Western Cape, South Africa. Addiction. 108:725–732.
   PubMed Web of Science ®Google Scholar
• Reus VI, Fochtmann LJ, Bukstein O, Eyler AE, Hilty DM, Horvitz-Lennon M, Mahoney J, Pasic J, Weaver M, Wills CD, et al. 2018. The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry. 175:86–90.
   PubMed Web of Science ®Google Scholar
• Reynolds KD, Coombs DW, Lowe JB, Peterson PL, Gayoso E. 1995. Evaluation of a self-help program to reduce alcohol consumption among pregnant women. Int J Addict. 30:427–443.
   PubMed Web of Science ®Google Scholar
• Robinson M, Oddy WH, McLean NJ, Jacoby P, Pennell CE, de Klerk NH, Zubrick SR, Stanley FJ, Newnham JP. 2010. Low-moderate prenatal alcohol exposure and risk to child behavioural development: a prospective cohort study. BJOG. 117:1139–1150.
   PubMed Web of Science ®Google Scholar
• Rolland B, Paille F, Gillet C, Rigaud A, Moirand R, Dano C, Dematteis M, Mann K, Aubin HJ. 2016. Pharmacotherapy for alcohol dependence: the 2015 recommendations of the French Alcohol Society, issued in partnership with the European Federation of Addiction Societies. CNS Neurosci Ther. 22:25–37.
   PubMed Web of Science ®Google Scholar
• Roozen S, Peters GJ, Kok G, Townend D, Nijhuis J, Curfs L. 2016. Worldwide prevalence of fetal alcohol spectrum disorders: a systematic literature review including meta-analysis. Alcohol Clin Exp Res. 40:18–32.
   PubMed Web of Science ®Google Scholar
• Rosner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M. 2010a. Acamprosate for alcohol dependence. Cochrane Database Syst Rev. (9):CD004332.
   PubMed Web of Science ®Google Scholar
• Rosner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. 2010b. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev. (12):CD001867.
   PubMed Web of Science ®Google Scholar
• Royal College of Obstetricians and Gynaecologists. 2006. Alcohol consumption and the outcomes of pregnancy (RCOG Statement, No.5). London: Royal College of Obstetricians and Gynaecologists.
   Google Scholar
• Russell M, Martier SS, Sokol RJ, Mudar P, Jacobson S, Jacobson J. 1996. Detecting risk drinking during pregnancy: a comparison of four screening questionnaires. Am J Public Health. 86:1435–1439.
   PubMed Web of Science ®Google Scholar
• Rustembegovic A, Sofic E, Kroyer G. 2002. A pilot study of Topiramate (Topamax) in the treatment of tonic-clonic seizures of alcohol withdrawal syndromes. Med Arh. 56:211–212.
   PubMedGoogle Scholar
• Saia KA, Schiff D, Wachman EM, Mehta P, Vilkins A, Sia M, Price J, Samura T, DeAngelis J, Jackson CV, et al. 2016. Caring for pregnant women with opioid use disorder in the USA: Expanding and improving treatment. Curr Obstet Gynecol Rep. 5:257–263.
   PubMed Web of Science ®Google Scholar
• Sarai M, Tejani AM, Chan AH, Kuo IF, Li J. 2013. Magnesium for alcohol withdrawal. Cochrane Database Syst Rev. 6:CD008358.
   Google Scholar
• Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. 1993. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol Consumption-II. Addiction. 88:791–804.
   PubMed Web of Science ®Google Scholar
• Saxen I, Saxen L. 1975. Associations between maternal intake of diazepam and oral clefts. Lancet. 306:498.
   Google Scholar
• Saxon AJ, Sloan KL, Reoux J, Haver VM. 1998. Disulfiram use in patients with abnormal liver function test results. J Clin Psychiatry. 59:313–316.
   PubMed Web of Science ®Google Scholar
• Schorling JB. 1993. The prevention of prenatal alcohol use: a critical analysis of intervention studies. J Stud Alcohol. 54:261–267.
   PubMed Web of Science ®Google Scholar
• Sedgh G, Singh S, Hussain R. 2014. Intended and unintended pregnancies worldwide in 2012 and recent trends. Stud Fam Plann. 45:301–314.
   PubMed Web of Science ®Google Scholar
• Selzer ML, Vinokur A, van Rooijen L. 1975. A self-administered Short Michigan Alcoholism Screening Test (SMAST). J Stud Alcohol. 36:117–126.
   PubMed Web of Science ®Google Scholar
• Skagerström J, Chang G, Nilsen P. 2011. Predictors of drinking during pregnancy: a systematic review. J Womens Health. 20:901–913.
   PubMed Web of Science ®Google Scholar
• Skinner MD, Lahmek P, Pham H, Aubin HJ. 2014. Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis. PLoS One. 9:e87366.
   PubMed Web of Science ®Google Scholar
• Sokol RJ, Martier SS, Ager W. 1989. The T-ACE questions: practical prenatal detection of risk-drinking. Am J Obstet Gynecol. 160:863–868.
   PubMed Web of Science ®Google Scholar
• Soyka M, Kranzler HR, Hesselbrock V, Kasper S, Mutschler J, Möller H-J. & the WFSBP Task Force on Treatment Guidelines for Substance Use Disorders. 2017. Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism, first revision. World J Biol Psychiatry. 18:86–119.
   PubMed Web of Science ®Google Scholar
• Stade BC, Bailey C, Dzendoletas D, Sgro M, Dowswell T, Bennett D. 2009. Psychological and/or educational interventions for reducing alcohol consumption in pregnant women and women planning pregnancy. Cochrane Database Syst Rev. 15:CD004228.
   Google Scholar
• Stika L, Elisova K, Honzakova L, Hrochova H, Plechatova H, Strnadova J, Skop B, Svihovec J, Váchova M, Vinar O. 1990. Effects of drug administration in pregnancy on children’s school behaviour. Pharm Weekbl Sci. 12:252–255.
   PubMedGoogle Scholar
• Streissguth A, Barr H, Kogan J, Bookstein F. 1997. Primary and secondary disabilities in fetal alcohol syndrome. In:Streissguth A, Kanter J, editors. The challenge of fetal alcohol syndrome: overcoming secondary disabilities. Seattle: University of Washington Press.
   Google Scholar
• Substance Abuse and Mental Health Services Administration and National Institute on Alcohol Abuse and Alcoholism (SAMHSA). 2015. Medication for the Treatment of Alcohol Use Disorder: A Brief Guide. HHS Publication No. (SMA) 15-4907. Rockville, MD: Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. 1989. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 84:1353–1357.
   PubMedGoogle Scholar
• Sutter-Dallay AL, Riecher-Rössler A. 2016. Psychotropic drugs and the perinatal period. In: Sutter-Dallay AL, Glangeaud-Freudenthal NM-C, Riecher-Rössler A, editors. Joint care of parents and infants in perinatal psychiatry. Berlin, Heidelberg: Springer; p. 79–92.
   Google Scholar
• Thompson A, Owens L, Richardson P, Pirmohamed M. 2017. Systematic review: baclofen dosing protocols for alcohol use disorders used in observational studies. Neuropsychopharmacol. 27:1077–1089.
   Web of Science ®Google Scholar
• Thompson BL, Levitt P, Stanwood GD. 2009. Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nat Rev Neurosci. 10:303–312.
   PubMed Web of Science ®Google Scholar
• Tzilos GK, Sokol RJ, Ondersma SJ. 2011. A randomized phase I trial of a brief computer-delivered intervention for alcohol use during pregnancy. J Womens Health (Larchmt). 20:1517–1524.
   PubMed Web of Science ®Google Scholar
• Ungur LA, Neuner B, John S, Wernecke K, Spies C. 2013. Prevention and therapy of alcohol withdrawal on intensive care units: systematic review of controlled trials. Alcohol Clin Exp Res. 37:675–686.
   PubMed Web of Science ®Google Scholar
• Van Munster BC, Korevaar JC, de Rooij SE, Levi M, Zwinderman AH. 2007. Genetic polymorphisms related to delirium tremens: a systematic review. Alcohol Clin Exp Res. 31:177–184.
   PubMed Web of Science ®Google Scholar
• Vaughn AJ, Carzoli RP, Sanchez-Ramos L, Murphy S, Khan N, Chiu T. 1993. Community-wide estimation of illicit drug use in delivering women: prevalence, demographics, and associated risk factors. Obstet Gynecol. 82:92–96.
   PubMed Web of Science ®Google Scholar
• Veiby G, Daltveit AK, Engelsen BA, Gilhus NE. 2014. Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J Neurol. 261:579–588.
   PubMed Web of Science ®Google Scholar
• Veroniki AA, Cogo E, Rios P, Straus SE, Finkelstein Y, Kealey R, Reynen E, Soobiah C, Thavorn K, Hutton B, et al. 2017. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congental malformations and prenatal outcomes. BMC Med. 15:95.
   PubMed Web of Science ®Google Scholar
• Viggedal G, Hagberg BS, Laegreid L, Aronsson M. 1993. Mental development in late infancy after prenatal exposure to benzodiazepines-a prospective study. J Child Psychol Psychiatry. 34:295–305.
   PubMed Web of Science ®Google Scholar
• Waye C, Wong M, Lee S. 2015. Implementation of a CIWA-Ar alcohol withdrawal protocol in a veterans hospital. South Med J. 108:23–28.
   PubMed Web of Science ®Google Scholar
• Weatherby SJ, Woolner P, Clarke CE. 2004. Pregnancy in stiff-limb syndrome. Mov Disord. 19:852–854.
   PubMed Web of Science ®Google Scholar
• Weinberg J, Sliwowska JH, Lan N, Hellemans KG. 2008. Prenatal alcohol exposure: foetal programming, the hypothalamic-pituitary-adrenal axis and sex differences in outcome. J Neuroendocrinol. 20:470–488.
   PubMed Web of Science ®Google Scholar
• Wendell AD. 2013. Overview and epidemiology of substance abuse in pregnancy. Clin Obstet Gynecol. 56:91–96.
   PubMed Web of Science ®Google Scholar
• Whitehall JS. 2007. National guidelines on alcohol use during pregnancy: a dissenting opinion. Med J Aust. 186:35–37.
   PubMed Web of Science ®Google Scholar
• Williams N. 2014. The CAGE questionnaire. Occup Med (Lond). 64:473–474.
   PubMedGoogle Scholar
• Windham GC, Von Behren J, Fenster L, Schaefer C, Swan SH. 1997. Moderate maternal alcohol consumption and risk of spontaneous abortion. Epidemiology. 8:509–514.
   PubMed Web of Science ®Google Scholar
• Winhusen T, Kropp F, Babcock D, Hague D, Erickson SJ, Renz C, Rau L, Lewis D, Leimberger J, Somoza E. 2008. Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users. J Subst Abuse Treat. 35:161–173.
   PubMed Web of Science ®Google Scholar
• Winterfeld U, Merlob P, Baud D, Rousson V, Panchaud A, Rothuizen LE, Bernard N, Vial T, Yates LM, Pistelli A, et al. 2016. Pregnancy outcome following maternal exposure to pregabalin may call for concern. Neurology. 86:2251–2257.
   PubMed Web of Science ®Google Scholar
• Wlodarczyk BJ, Palacios AM, George TM, Finnell RH. 2012. Antiepileptic drugs and pregnancy outcomes. Am J Med Genet A. 158A:2071–2090.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). 1992. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines 10th Revision (ICD-10). Geneva: World Health Organization.
   Google Scholar
• World Health Organization (WHO). 2014. Guidelines for the identification and management of substance use and substance use disorders in pregnancy. Geneva: World Health Organization.
   Google Scholar
• Wright TE, Terplan M, Ondersma SJ, Boyce C, Yonkers K, Chang G, Creanga AA. 2016. The role of screening, brief intervention, and referral to treatment in the perinatal period. Am J Obstet Gynecol. 215:539–547.
   PubMed Web of Science ®Google Scholar
• Yeganeh N, Dillavou C, Simon M, Gorbach P, Santos B, Fonseca R, Saraiva J, Melo M, Nielsen-Saines K. 2013. Audio computer-assisted survey instrument versus face-to-face interviews: optimal method for detecting high-risk behaviour in pregnant women and their sexual partners in the south of Brazil. Int J STD AIDS. 24:279–285.
   PubMed Web of Science ®Google Scholar
• Yerby MS. 2003. Management issues for women with epilepsy: neural tube defects and folic supplementation. Neurology. 61:S23–S26.
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Forray A, Howell HB, Gotman N, Kershaw T, Rounsaville BJ, Carroll KM. 2012. Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after delivery. Gen Hosp Psychiatry. 34:439–449.
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Gilstad-Hayden K, Forray A, Lipkind HS. 2017. Association of panic disorder, generalized anxiety disorder, and benzodiazepine treatment during pregnancy with risk of adverse birth outcomes. JAMA Psychiatry. 74:1145–1152.
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Gotman N, Kershaw T, Forray A, Howell HB, Rounsaville BJ. 2010. Screening for prenatal substance use: development of the substance use risk profile-pregnancy scale. Obstet Gynecol. 116:827–833.
   PubMed Web of Science ®Google Scholar
• Zagon IS, Tobias SW, Hytrek SD, McLaughlin PJ. 1998. Opioid receptor blockade throughout prenatal life confers long-term insensitivity to morphine and alters mu opioid receptors. Pharmacol Biochem Behav. 59:201–207.
   PubMed Web of Science ®Google Scholar